Changes of Subcutaneous Tissue Echogenicity During Facilitated Subcutaneous Immunoglobulin Application
نویسندگان
چکیده
منابع مشابه
Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
Immunoglobulin (Ig)-replacement therapy represents the mainstay of treatment for patients with primary antibody deficiency and is administered either intravenously (IVIg) or subcutaneously (SCIg). While hyaluronidase has been used in clinical practice for over 50 years, the development of a high-purity recombinant form of this enzyme (recombinant human hyaluronidase PH20) has recently enabled t...
متن کاملSubcutaneous adipose tissue classification
The developments in the technologies based on the use of autologous adipose tissue attracted attention to minor depots as possible sampling areas. Some of those depots have never been studied in detail. The present study was performed on subcutaneous adipose depots sampled in different areas with the aim of explaining their morphology, particularly as far as regards stem niches. The results dem...
متن کاملImmunoglobulin replacement treatment by rapid subcutaneous infusion.
Long term intravenous immunoglobulin (IVIG) infusion is an effective treatment for children with immunodeficiencies, but can be complicated by poor venous access, systemic adverse reactions, and the need for frequent hospital admission. Rapid subcutaneous immunoglobulin (SCIG) infusion has been found to be effective in adults with primary immunodeficiency. Twenty six children were treated with ...
متن کاملDosing Alternatives in Subcutaneous Immunoglobulin Therapy
Introduction Immunoglobulin G (IgG) replacement therapy is the standard care for patients with primary immune deficiency diseases (PIDDs). Previously, IgG had been administered mostly by intramuscular injection, but since the development of intravenous preparations (IVIg), the IV route has been predominant, especially in the United States. Subcutaneous infusion (SCIg) using small mechanical pum...
متن کاملNew Frontiers in Subcutaneous Immunoglobulin Treatment
Subcutaneous immunoglobulin (SCIG) treatment provides stable serum immunoglobulin G (IgG) levels, is associated with fewer systemic adverse events than intravenous immunoglobulin (IVIG) treatment, and offers the convenience of home therapy. In clinical practice, IVIG is still used preferentially for initiation of treatment in newly diagnosed patients with primary immunodeficiency (PI) and for i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Allergy and Clinical Immunology
سال: 2020
ISSN: 0091-6749
DOI: 10.1016/j.jaci.2019.12.256